Clinical Trial Update: Cara CDRS (Conduction Disturbance Risk Score) 1.0

View source ↗

Summary

Update on the Cara CDRS 1.0 study evaluating a Conduction Disturbance Risk Score in patients undergoing Transcatheter Aortic Valve Replacement.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Stenosis

Snippet

Sponsor: Cara Medical Ltd | Conditions: Transcatheter Aortic Valve Replacement | Status: COMPLETED